Kolmar BioTech, Inc. (KOSDAQ:215380)
South Korea · Delayed Price · Currency is KRW 1,824.00
+2.00 (0.11%)
At close: Nov 13, 2026
Kolmar BioTech Market Cap
Kolmar BioTech has a market cap or net worth of 30.7 billion as of November 13, 2026. It is the 35,660th most valuable company in the world and the 2,123rd biggest in South Korea. Its market cap has decreased by 19.65% in one year.
Market Cap
30.70B
Enterprise Value
46.41B
Revenue
40.30B
Global Rank
Country Rank
#2,123 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 27, 2017, Kolmar BioTech's market cap has decreased from 51.29B to 30.70B, a decrease of -40.15%. That is a compound annual growth rate of -5.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 30.70B | 3.58% |
| Dec 30, 2025 | 29.64B | 3.59% |
| Dec 30, 2024 | 28.61B | 5.65% |
| Dec 28, 2023 | 27.08B | -29.98% |
| Dec 29, 2022 | 38.68B | -52.23% |
| Dec 30, 2021 | 80.97B | -29.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 334.06B |
| DreamCIS | 98.89B |
| HLB bioStep | 75.19B |
| P&K Skin Research Center | 52.56B |
| SLS BIO | 26.89B |
| DT&CRO CO. | 26.14B |
| C&R Research | 22.94B |
| Curachem | 12.65B |